Workforce: Train AD/ADRD research and clinical health professionals (Milestone 11.J)
In Progress
Timeline Start - End
2016 - 2027Research Implementation Area
Enabling Technologies and Disease MonitoringAD-Related Dementias Focus
Promote education and training on multiple etiology cognitive impairment and dementia to increase the dementia capable workforce, advance researchers including from groups underrepresented in science, and foster inclusive research practices.
Success Criteria
- National AD/ADRD training program for researchers and healthcare professionals that fosters an inclusive workforce and research environment, focuses on multiple etiology cognitive impairment and dementia and its relationship to AD/ADRD diagnoses, and training on rigorous approaches to AD/ADRD research including in groups that experience health disparities.
Summary of Key Accomplishments
NIH's AD/ADRD program actively incentivizes, encourages, and seeks opportunities to develop research and training programs as key elements of the organization's mission and has established six new institutional training programs since 2020 (PAR-18-524 and PAR-22-021). The NIA and NINDS are engaged with various initiatives to support diverse perspectives in all levels of AD/ADRD research and clinical training and have created two new funding opportunities to assist postdoctoral researchers from diverse backgrounds to transition to independent faculty positions conducting AD/ADRD research.
The key accomplishments summary is current as of July 2022.
Accomplishments/Implementation Activities
Funding Initiatives
- PAR-17-072: Revision Awards to Institutional Training Programs to Advance Research on Alzheimer’s Disease and Alzheimer's Disease Related Dementias (T32)
- RFA-AG-17-063: Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease and AD-Related Dementias (T32)
- NOT-NS-19-003: Notice to Encourage Eligible NINDS Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Initiative Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research"
- NOT-NS-20-089: Notice to Encourage Eligible NINDS Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Initiative Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research"
- NOT-NS-21-047: Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees
- PAR-21-112: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)
- PAR-21-220: NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99)
- PAR-21-217: NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32)
- PAR-21-218: NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)
- PAR-22-021: NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
- PAR-22-022: NINDS Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Research Programs and Resources
- Diverse VCID: White Matter Lesion Etiology of Dementia in Diverse Populations
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)
- DetectCID
- Select projects funded in FY21
- Select projects funded in FY22
Research Highlights
Relevant Recommendations
- ADRD Summit 2016: Multiple Etiology Dementias (MED) Focus Area 1: Improved Diagnostic Skills in the Community, Recommendation 3
- 2022 ADRD Summit: Multiple Etiology Dementias (MED) Milestone 7, Priority 2